Summa Health System

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Summa Health System sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).

13 total trials none currently recruiting 10 completed top decile by trial count

Summa Health System: 13 sponsored US clinical trials, none currently recruiting.

Summa Health System sponsors 13 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 10 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Oral Candidiasis, with 1 trials.

Top-decile sponsor footprint

Summa Health System ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 32/100

10 of 13 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (76.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

13 total, page 1 of 1

COMPLETED Phase 4

Low Dose Ketamine Infusion for Analgesia in the Emergency Department to Reduce Side Effects

NCT05518877
TERMINATED

Assay to Measure Beta Blocker Adherence

NCT05251974
TERMINATED

Impact of Breast Magnetic Resonance Imaging (MRI) on Mastectomy Rates

NCT01166581
COMPLETED

Bariatric Surgery and Obstructive Sleep Apnea

NCT01243463
COMPLETED NA

Better Weight-Better Sleep (BWBS) Trial

NCT00979784
COMPLETED NA

Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain

NCT00554320
COMPLETED Phase 4

The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye

NCT00705757
COMPLETED Phase 1

The Effect of Action Control Based Intervention on Adherence After Cardiac Rehabilitaiton

NCT00602485
COMPLETED NA

Acidophilus for the Treatment and Prevention of Oral Candidiasis in Patients Undergoing Radiation Therapy

NCT00768794
COMPLETED

Smart Heart Study: Cognitive Benefits of Cardiac Rehabilitation

NCT00320905
COMPLETED

Immunologic Function in the Elderly After Injury

NCT00447135
COMPLETED Phase 2

A Pilot Study to Investigate Fenoldopam Usage in the Prevention of Postoperative Renal Dysfunction in Patients at a High Risk for Renal Impairment During Cariopulmonary Bypass for Cardiac Surgery

NCT00467181
TERMINATED Phase 2

Study of Advanced Bulky Malignancies With Spatially Fractioned Radiation Therapy

NCT00765570

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2
Phase 4 2

Therapeutic Areas

Oral Candidiasis 1
Chronic Pelvic Pain 1
Interstitial Cystitis 1
Post Traumatic Stress Disorder 1
Irritable Bowel Syndrome 1
Fibromyalgia 1

How the Summa Health System archive is shaped

13 indexed studies, none listed as recruiting (0% open); 10 completed (77%).

Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).

Top condition: Oral Candidiasis (1 trial), 5 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Summa Health System: archived-pipeline peers nationwide

Peers matched on 13 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Summa Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%2%4%6%8%10% Total trials Recruiting share Summa Health SystemAdaptimmuneAgennixAkili Interactive LabsAlumis10xBio22nd Century Group23andMe3-C Institute for Social Development
Summa Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Summa Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 13 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Summa Health System page

13 registered trials is a research-attention snapshot, not an endorsement of Summa Health System or any single study.

  • None of Summa Health System's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Oral Candidiasis is the condition Summa Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Oral Candidiasis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Summa Health System pipeline card: 13 registered trials from official public datasets.Report a data error.